2.71
1.88%
+0.05
After Hours:
2.705
-0.005
-0.18%
Augmedix Inc stock is currently priced at $2.71, with a 24-hour trading volume of 242.90K.
It has seen a +1.88% increased in the last 24 hours and a -35.17% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $2.61 pivot point. If it approaches the $2.76 resistance level, significant changes may occur.
Previous Close:
$2.66
Open:
$2.71
24h Volume:
242.90K
Market Cap:
$132.70M
Revenue:
$44.86M
Net Income/Loss:
$-19.17M
P/E Ratio:
-4.8436
EPS:
-0.5595
Net Cash Flow:
$-18.55M
1W Performance:
-4.91%
1M Performance:
-35.17%
6M Performance:
-44.35%
1Y Performance:
-11.15%
Augmedix Inc Stock (AUGX) Company Profile
Name
Augmedix Inc
Sector
Industry
Phone
888 669 4885
Address
111 Sutter Street, Suite 1300, San Francisco
Augmedix Inc Stock (AUGX) Latest News
Augmedix to Participate in Upcoming Investor Conferences in May and June 2024
GlobeNewswire Inc.
Analyst Ratings For Augmedix
Benzinga
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
GlobeNewswire Inc.
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
Benzinga
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
GlobeNewswire Inc.
Augmedix Inc Stock (AUGX) Financials Data
Augmedix Inc (AUGX) Revenue 2024
AUGX reported a revenue (TTM) of $44.85 million for the quarter ending December 31, 2023, a +45.01% rise year-over-year.
Augmedix Inc (AUGX) Net Income 2024
AUGX net income (TTM) was -$19.17 million for the quarter ending December 31, 2023, a +21.59% increase year-over-year.
Augmedix Inc (AUGX) Cash Flow 2024
AUGX recorded a free cash flow (TTM) of -$18.55 million for the quarter ending December 31, 2023, a -2.01% decrease year-over-year.
Augmedix Inc (AUGX) Earnings per Share 2024
AUGX earnings per share (TTM) was -$0.4516 for the quarter ending December 31, 2023, a +31.52% growth year-over-year.
About Augmedix Inc
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
Cap:
|
Volume (24h):